Clinical trial

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

NCT00297778

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Pramipexole Normalized identity: pramipexoleView linked drug · Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-03-01

PhasePHASE4

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Depressionverified · MONDO: depressive disorder

Interventions

PramipexoleDRUG · verified · RxNorm: pramipexole

PlaceboOTHER

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

BarcelonaSpain3 BerlinGermany3 Saint PetersburgRussia3 LilleFrance3 BucharestRomania3 Cape TownSouth Africa3 MoscowRussia2 StockholmSweden2 MadridSpain1 MilanItaly1 MarseilleFrance1 ViennaAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00297778 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.